Further investigation on PTPRK, a Smad target gene indentified in this study, indicates that while TGF-β upregulates PTPRK expression in both tumor and nontumor mammary cells, HER2 overexpression downregulates PTPRK. The gene discussed is ERBB2; the disease is neoplasm.